Atara Biotherapeutics resubmits tab-cel application to FDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GOOGL
8. GMAB
9. USO
10. AMD

Go back to Atara Biotherapeutics resubmits tab-cel application to FDA

Atara Biotherapeutics Provides Regulatory and Business Updates on Tabelecleucel (Tab-cel®)

July 14, 2025 8:00 AM EDT

Atara Biotherapeutics Resubmits Tabelecleucel (Tab-cel®) Biologics License Application for Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease to the U.S. FDA

Approval of BLA Would Trigger $40 Million Milestone Payment from Pierre Fabre Laboratories

THOUSAND OAKS, Calif.--(BUSINESS... More